QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
NYSE:UNH

UnitedHealth Group Stock Competitors

$424.38
-0.24 (-0.06 %)
(As of 10/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$423.40
$427.82
50-Day Range
$387.01
$429.71
52-Week Range
$299.60
$433.50
Volume1.60 million shs
Average Volume2.98 million shs
Market Capitalization$400.16 billion
P/E Ratio28.03
Dividend Yield1.37%
Beta0.77

UnitedHealth Group (NYSE:UNH) Vs. JNJ, NVO, PFE, TMO, LLY, ABT, MRK, ABBV, AZN, and NVS

Should you be buying UnitedHealth Group stock or one of its competitors? The main competitors of UnitedHealth Group include Johnson & Johnson (JNJ), Novo Nordisk A/S (NVO), Pfizer (PFE), Thermo Fisher Scientific (TMO), Eli Lilly and (LLY), Abbott Laboratories (ABT), Merck & Co., Inc. (MRK), AbbVie (ABBV), AstraZeneca (AZN), and Novartis (NVS). These companies are all part of the "medical" sector.

UnitedHealth Group vs.

Novo Nordisk A/S (NYSE:NVO) and UnitedHealth Group (NYSE:UNH) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, community ranking, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

In the previous week, UnitedHealth Group had 76 more articles in the media than Novo Nordisk A/S. MarketBeat recorded 88 mentions for UnitedHealth Group and 12 mentions for Novo Nordisk A/S. UnitedHealth Group's average media sentiment score of 0.63 beat Novo Nordisk A/S's score of 0.44 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Novo Nordisk A/S
1 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
UnitedHealth Group
17 Very Positive mention(s)
12 Positive mention(s)
24 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

UnitedHealth Group received 1218 more outperform votes than Novo Nordisk A/S when rated by MarketBeat users. Likewise, 81.62% of users gave UnitedHealth Group an outperform vote while only 60.27% of users gave Novo Nordisk A/S an outperform vote.

CompanyUnderperformOutperform
Novo Nordisk A/SOutperform Votes
358
60.27%
Underperform Votes
236
39.73%
UnitedHealth GroupOutperform Votes
1576
81.62%
Underperform Votes
355
18.38%

5.6% of Novo Nordisk A/S shares are held by institutional investors. Comparatively, 86.2% of UnitedHealth Group shares are held by institutional investors. 0.1% of Novo Nordisk A/S shares are held by company insiders. Comparatively, 0.6% of UnitedHealth Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

UnitedHealth Group has a consensus price target of $468.17, indicating a potential upside of 10.32%. Given UnitedHealth Group's stronger consensus rating and higher probable upside, analysts clearly believe UnitedHealth Group is more favorable than Novo Nordisk A/S.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Novo Nordisk A/S
2 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.42
UnitedHealth Group
0 Sell rating(s)
1 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
3.00

Novo Nordisk A/S has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, UnitedHealth Group has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500.

Novo Nordisk A/S has a net margin of 34.17% compared to UnitedHealth Group's net margin of 5.33%. Novo Nordisk A/S's return on equity of 72.72% beat UnitedHealth Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Novo Nordisk A/S 34.17% 72.72% 30.72%
UnitedHealth Group 5.33% 22.15% 7.65%

UnitedHealth Group has higher revenue and earnings than Novo Nordisk A/S. UnitedHealth Group is trading at a lower price-to-earnings ratio than Novo Nordisk A/S, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novo Nordisk A/S$19.45 billion12.67$6.46 billion$2.7637.92
UnitedHealth Group$257.14 billion1.56$15.40 billion$16.8825.14

Novo Nordisk A/S pays an annual dividend of $0.77 per share and has a dividend yield of 0.7%. UnitedHealth Group pays an annual dividend of $5.80 per share and has a dividend yield of 1.4%. Novo Nordisk A/S pays out 27.9% of its earnings in the form of a dividend. UnitedHealth Group pays out 34.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. UnitedHealth Group has increased its dividend for 12 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

UnitedHealth Group beats Novo Nordisk A/S on 16 of the 22 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UNH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UnitedHealth Group (NYSE:UNH) vs. Its Competitors

TypeUnitedHealth GroupHospital & medical service plans IndustryMedical SectorNYSE Exchange
Dividend Yield1.37%1.28%1.97%2.77%
P/E Ratio28.0316.2732.9527.64
Net Margins5.33%2.17%-3,875.79%-85.73%

UnitedHealth Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JNJ
Johnson & Johnson
2.7714 of 5 stars
$163.87
-2.3%
$190.38
-16.2%
+8.1%$431.38B$82.58B24.64134,500Earnings Report
News Coverage
NVO
Novo Nordisk A/S
1.3831 of 5 stars
$104.65
-1.2%
N/A+45.6%$246.43B$19.45B34.202,020Analyst Upgrade
Analyst Revision
News Coverage
PFE
Pfizer
3.0029 of 5 stars
$42.09
-1.8%
$44.00
-4.5%
+8.9%$235.99B$41.91B18.0678,500
TMO
Thermo Fisher Scientific
2.4478 of 5 stars
$592.10
-0.7%
$611.11
-3.2%
+25.5%$232.94B$32.22B27.4513,000
LLY
Eli Lilly and
2.8764 of 5 stars
$242.31
-1.4%
$259.06
-6.9%
+63.6%$232.38B$24.54B36.332,020Upcoming Earnings
Dividend Announcement
ABT
Abbott Laboratories
2.895 of 5 stars
$119.34
-2.1%
$131.27
-10.0%
+6.5%$211.57B$34.61B33.62109,000Upcoming Earnings
MRK
Merck & Co., Inc.
2.9958 of 5 stars
$79.49
-2.9%
$93.31
-17.4%
-3.4%$201.22B$47.99B36.3073,500Short Interest ↓
Gap Up
ABBV
AbbVie
3.54 of 5 stars
$107.45
-0.0%
$126.67
-17.9%
+24.5%$189.88B$45.80B28.962,020
AZN
AstraZeneca
2.7464 of 5 stars
$60.17
-1.5%
$124.00
-106.1%
+11.8%$186.42B$26.62B41.7976,100Analyst Report
Analyst Revision
NVS
Novartis
2.2213 of 5 stars
$83.15
-1.0%
$108.50
-30.5%
-4.5%$185.98B$48.66B21.05105,794Upcoming Earnings
MDT
Medtronic
3.0967 of 5 stars
$122.20
-1.2%
$144.55
-18.3%
+9.6%$164.23B$30.12B42.7390,000Analyst Report
News Coverage
MRNA
Moderna
1.9564 of 5 stars
$333.61
-0.4%
$195.62
-41.4%
+352.9%$134.66B$803.40M41.601,300Insider Selling
BMY
Bristol-Myers Squibb
3.3648 of 5 stars
$57.59
-1.1%
$72.00
-25.0%
-7.0%$127.97B$42.52B-25.3730,250Analyst Revision
SNY
Sanofi
2.2083 of 5 stars
$48.06
-0.1%
N/A-4.5%$121.19B$41.17B17.4899,412Short Interest ↑
ISRG
Intuitive Surgical
2.1764 of 5 stars
$336.30
-1.2%
$327.89
-2.5%
+32.4%$120.05B$4.36B25.138,081News Coverage
High Trading Volume
AMGN
Amgen
3.1631 of 5 stars
$206.78
-1.8%
$244.00
-18.0%
-13.8%$117.42B$25.42B21.0424,300Analyst Revision
GSK
GlaxoSmithKline
1.8148 of 5 stars
$39.17
-1.3%
N/A+5.7%$105.47B$43.79B16.5394,066Analyst Report
SYK
Stryker
2.7822 of 5 stars
$270.86
-3.3%
$286.43
-5.7%
+17.0%$102.14B$14.35B49.612,020
ZTS
Zoetis
2.3548 of 5 stars
$204.44
-0.8%
$203.11
-0.7%
+24.0%$96.89B$6.68B51.2411,300Dividend Announcement
ANTM
Anthem
3.2664 of 5 stars
$393.75
-1.4%
$421.60
-7.1%
+30.8%$96.00B$121.87B23.1383,400Upcoming Earnings
GILD
Gilead Sciences
3.3672 of 5 stars
$66.90
-1.5%
$75.60
-13.0%
+6.3%$83.88B$24.69B16.3213,600Analyst Revision
News Coverage
HCA
HCA Healthcare
2.5683 of 5 stars
$248.68
-0.8%
$258.47
-3.9%
+82.5%$79.61B$51.53B17.06235,000Upcoming Earnings
News Coverage
EW
Edwards Lifesciences
2.2031 of 5 stars
$115.00
-3.4%
$118.44
-3.0%
+30.2%$71.68B$4.39B49.3614,900Insider Selling
BDX
Becton, Dickinson and
2.6309 of 5 stars
$242.73
-1.8%
$273.63
-12.7%
+0.6%$69.71B$17.12B38.1172,000Analyst Upgrade
BNTX
BioNTech
1.4272 of 5 stars
$262.85
-0.7%
$254.08
-3.3%
+177.5%$63.75B$550.91M13.752,020Gap Up
BSX
Boston Scientific
2.3004 of 5 stars
$44.13
-3.0%
$49.13
-11.3%
+11.3%$62.83B$9.91B133.732,020Insider Selling
ILMN
Illumina
1.8364 of 5 stars
$414.08
-0.9%
$435.50
-5.2%
+25.8%$60.75B$3.24B79.337,825Analyst Report
REGN
Regeneron Pharmaceuticals
2.9544 of 5 stars
$552.11
-1.6%
$698.50
-26.5%
-9.4%$59.05B$8.50B9.919,123
HUM
Humana
2.5334 of 5 stars
$441.50
-0.7%
$485.18
-9.9%
+0.2%$56.73B$77.16B23.3448,700
IDXX
IDEXX Laboratories
1.9964 of 5 stars
$640.99
-0.4%
$675.00
-5.3%
+50.6%$54.53B$2.71B76.409,300Short Interest ↓
DXCM
DexCom
2.3562 of 5 stars
$550.05
-1.6%
$516.93
-6.0%
+33.6%$53.22B$1.93B104.775,500Analyst Downgrade
Insider Selling
VRTX
Vertex Pharmaceuticals
2.7803 of 5 stars
$185.41
-2.5%
$266.61
-43.8%
-17.1%$48.10B$6.21B24.463,400Analyst Revision
News Coverage
ALGN
Align Technology
2.3276 of 5 stars
$594.27
-0.1%
$688.85
-15.9%
+76.8%$46.95B$2.47B67.6818,070Short Interest ↓
News Coverage
TAK
Takeda Pharmaceutical
1.8148 of 5 stars
$14.10
-1.0%
N/A-16.3%$44.62B$30.17B9.662,021News Coverage
DIDI
DiDi Global
0.6 of 5 stars
$8.56
-3.7%
$25.00
-192.1%
N/A$41.29B$21.63B0.0015,914
PHG
Koninklijke Philips
1.2998 of 5 stars
$44.94
-3.9%
N/A-11.5%$40.68B$22.31B34.0581,592Earnings Report
Analyst Report
Short Interest ↑
News Coverage
Gap Up
High Trading Volume
BIIB
Biogen
2.5514 of 5 stars
$268.13
-0.6%
$379.65
-41.6%
-3.7%$39.96B$13.44B21.529,100Upcoming Earnings
Analyst Report
Analyst Revision
BAX
Baxter International
2.8498 of 5 stars
$79.68
-1.9%
$91.18
-14.4%
-4.4%$39.83B$11.67B36.382,020
ALC
Alcon
2.0481 of 5 stars
$81.16
-3.5%
$85.20
-5.0%
+26.6%$39.62B$6.83B219.3520,000Gap Up
RMD
ResMed
2.0598 of 5 stars
$260.16
-1.2%
$241.50
-7.2%
+42.1%$37.90B$3.20B80.307,770Insider Selling
CNC
Centene
2.7539 of 5 stars
$64.71
-1.1%
$82.81
-28.0%
-3.3%$37.73B$111.12B53.0471,300Upcoming Earnings
BGNE
BeiGene
1.8964 of 5 stars
$376.00
-4.0%
$356.88
-5.1%
+14.0%$35.09B$308.87M-25.845,300Analyst Revision
SGEN
Seagen
2.1231 of 5 stars
$174.19
-1.3%
$181.90
-4.4%
-14.4%$31.69B$2.18B53.432,092
MCK
McKesson
2.6 of 5 stars
$202.59
-0.9%
$224.13
-10.6%
+28.2%$31.34B$238.23B-7.1767,500
ZBH
Zimmer Biomet
2.5621 of 5 stars
$148.92
-2.7%
$179.95
-20.8%
-1.3%$31.10B$7.02B34.1620,000
WST
West Pharmaceutical Services
2.5381 of 5 stars
$417.57
-2.1%
$475.00
-13.8%
+39.9%$30.89B$2.15B61.059,200News Coverage
Positive News
GMAB
Genmab A/S
1.7655 of 5 stars
$45.30
-1.8%
$44.71
-1.3%
+21.0%$29.76B$1.55B73.06781Positive News
LH
Laboratory Co. of America
2.3298 of 5 stars
$276.05
-0.6%
$316.57
-14.7%
+37.8%$26.61B$13.98B9.4272,400
HZNP
Horizon Therapeutics Public
2.345 of 5 stars
$112.88
-0.1%
$119.89
-6.2%
+41.8%$25.50B$2.20B50.171,395
ABC
AmerisourceBergen
2.9231 of 5 stars
$119.84
-1.2%
$137.00
-14.3%
+19.0%$24.90B$189.89B-6.5021,500
This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.